Yale New Haven Hospital announces plans to build state-of-the-art Neurosciences Center on Saint Raphael Campus in New Haven

Monday, April 29, 2019
YNHH SRC Neuroscience Center

New Haven, CT (April 29, 2019) –
Joined by community members and elected officials, Yale New Haven Hospital announced the launch of a major healthcare investment on its Saint Raphael campus in New Haven. The $838 million project would include two new patient facilities and focus on innovation in the neurosciences. It will be the largest project of its kind in state history and will provide enhanced access to state-of-the-art care for patients.

“We firmly believe that this new facility will change the landscape of healthcare and draw patients from throughout the region and nation,” said Marna P. Borgstrom, CEO of Yale New Haven Health and Yale New Haven Hospital. “While this represents a landmark investment in our patients, it was also very important to us that we move this project forward in full partnership with the City of New Haven, the State and the local community. We are proud to work together to advance the promise of exceptional care for our patients.”

The new 505,000 square-foot project, featuring 204 inpatient beds, will fulfill a vision of providing a unique setting for patients seeking innovative care from movement disorders to neuro-regeneration. The project will also allow Yale New Haven to decant portions of the existing East Pavilion, which was built in 1953 and includes more than 300 patient beds.

“Yale New Haven Health is the largest private employer in Connecticut and this project signals their focused desire to continue investing in our state,” said Governor Ned Lamont. “We are very fortunate that this type of investment will stretch the boundaries of medicine and likely lead to breakthroughs in the treatment of neurologic disease. So as we tout the hundreds of new construction and permanent jobs this project represents, we are also humbled by the direct impact it will have on the health of our citizens.”

“We embrace the partnership and appreciate the spirit of collaboration Yale New Haven brings to the table with this project and we recognize the exceptional value they provide, both to city residents and the entire region,” said Mayor Toni Harp, city of New Haven. “New Haven is the beneficiary of the great patient care they provide – on behalf of all city residents I applaud the ongoing support of Yale New Haven Health in our city.”

The hospital has pledged its ongoing support to City of New Haven in conjunction with the project. Yale New Haven has agreed to work with the City to drive better quality health outcomes for City employees at lower costs. To bridge to those savings, the hospital has agreed to a one-time voluntary bridge payment of $3 million in addition to its ongoing support. Yale New Haven has also agreed to pre-pay $8.9 million in building fees associated with the project.

“The impact this new facility will have on patient care is enormous,” said Robert J. Alpern, MD, dean, Yale School of Medicine. “Parkinson’s Disease, ALS, stroke and other neurological disorders take a tremendous toll on patients and their families. We hope to directly address these challenges through innovative research, education and exceptional patient care.”

The announcement comes as the boards of Yale New Haven Hospital and Yale New Haven Health provided their preliminary approvals earlier this month.

“We reviewed a number of options when considering this project,” said Mary Farrell, chair of Yale New Haven Hospital. “This represents an important investment on the Saint Raphael Campus. Consistent with our promise in 2012, this will allow us to further our goal to rebalance the two campuses, providing synergy and exceptional care at both locations.”

The project will be built within the existing footprint of the hospital campus, bordered by Sherman Avenue and George Street. It will shift the main entrance of the hospital from Chapel Street to George Street. An existing parking garage on Orchard Street will be extended to George Street to accommodate patients and a new 200-space underground garage will support the facility.

“We appreciate the hospital’s effort to bring our elected and community leaders in from the start” said Tyisha Walker-Myers, president, New Haven Board of Alders. “As we review the important details of this project, we appreciate that transparency and we recognize the value it brings to our city. This development demonstrates the benefit of commitment to our area. As the representative of the 23rd ward, I look forward to continued conversations on how the hospital can further support the neighborhood”

“Yale New Haven Hospital and Yale School of Medicine have been nationally recognized for innovation in the neurosciences for years. Working collaboratively, we believe we can bring the most advanced care – built upon groundbreaking research – to our state and region,” said Richard D’Aquila, president of Yale New Haven Health and Yale New Haven Hospital. “We look forward to finalizing the details of the project over the next several months and submitting it for approval this fall.”

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

08/17/20

Yale New Haven Hospital and Yale School of Medicine partner to test the new COVID-19 vaccine

New Haven, CT (August 17, 2020) – Yale New Haven Hospital and Yale School of Medicine today announced the start of Phase 3 of the Pfizer vaccine trial at the hospital. This groundbreaking study is intended to be one of several vaccine trials to be undertaken in the hopes of finding the most scientifically validated vaccine in the shortest amount of time.

08/11/20

Christopher O’Connor to become president of Yale New Haven Health

New Haven, CT (August 11, 2020) – Working in direct partnership with Health System CEO Marna Borgstrom, Christopher O’Connor will become the new president of Yale New Haven Health (YNHHS) effective October 5, 2020.

07/31/20

Yale New Haven president Richard D’Aquila to step down after nearly 15 years of service with Yale New Haven Health

New Haven, CT (July 31, 2020) – After nearly 15 years of service, Richard D’Aquila has announced his decision to transition out of his role as president of Yale New Haven Hospital and the Health System effective October 5, 2020.